---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-21-001231"
form_type: "8-K"
ticker: "BHIC"
cik: "0001784440"
company_name: "BioScience Health Innovations, Inc."
filed_at: "2021-09-01T23:59:59+00:00"
generated_at: "2026-06-29T06:33:12.445613+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director

## Summary
- Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.
- Ivan Homici resigned as director, President, Treasurer, and Secretary on July 29, 2021; Justin Earl replaced him in all roles.
- Justin Earl, age 47, previously served as President of Strategic Junction since 2011, focusing on business continuity and risk management.
- No related party transactions or other arrangements existed between the company and Mr. Earl.

## SEC filing metadata
- accession: 0001185185-21-001231
- form_type: 8-K
- ticker: BHIC
- cik: 0001784440
- company_name: BioScience Health Innovations, Inc.
- filed_at: 2021-09-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/nowtransit20210901_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-21-001231
- JSON: https://secwatch.observer/filing/0001185185-21-001231.json
- Plain text: https://secwatch.observer/filing/0001185185-21-001231.txt

## Key facts
- Executive change
  Ivan Homici resigned as President at BioScience Health Innovations, Inc..
  - Action: resigned
  - Role: President
  source text: On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm
- Executive change
  Justin Earl was appointed as President at BioScience Health Innovations, Inc..
  - Action: appointed
  - Role: President
  source text: On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.